Compare Devon Energy Corp (DVN) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs Globus Medical Inc. Class A Common Stock — how do they compare? Devon Energy Corp trades at $50.23 (market cap $54.91B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: Devon Energy Corp is far larger — about 5.4× Globus Medical Inc. Class A Common Stock's market cap, and Devon Energy Corp pays a 2.56% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Devon Energy Corp for 136 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| DVN | GMED | |
|---|---|---|
Market Cap | $54.91B | $10.25B |
Volume | 8,928,382 | 1,059,528 |
Sector | Energy | Health |
52-Week High | $52.07 | $96.82 |
52-Week Low | $31.74 | $58.33 |
Typical Hold Time | 136 Days | 0 Days |
Enterprise Value | $65.65B | $9.76B |
Dividend Yield | 2.56% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $50.21, up 2.55% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $62.44 implying significant upside. Recent financials show revenue of $17.19B in 2025 with a net income margin of 16.67%, while valuation ratios like a P/E of 10.92 appear attractive. Activist investor Toms Capital is urging strategic review, including a potential sale, as highlighted in recent news (CNBC, 2026-09-23).
The outlook is positive given strong analyst support (72% buy ratings) and projected 2026 revenue growth to $19.7B. Key risks include oil price volatility and execution of potential asset sales. The stock presents a value opportunity with upside to price targets, though dependent on commodity markets and corporate strategy developments.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
